NCT01728935View on ClinicalTrials.gov

Tenofovir in Asian Chronic Hepatitis B Patients

NACompletedINTERVENTIONAL

Enrollment

141

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2012

Study Completion Date

March 31, 2013

Conditions

Chronic Hepatitis B

Interventions

DRUG

Tenofovir disoproxil

Tenofovir disoproxil 300mg daily

Trial Locations (1)

Unknown

Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

The University of Hong Kong

OTHER

NCT01728935 - Tenofovir in Asian Chronic Hepatitis B Patients | Biotech Hunter | Biotech Hunter